Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status
about
Acute Biphasic Effects of AyahuascaBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice.Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).
P2860
Q28548629-D69DED7E-87D4-4BFC-A49B-3AE1507DF947Q30358201-CA0F6981-6614-4B97-BEFB-AED15CB1D482Q35025821-7D63C16D-9664-4246-8D7C-627DD996D4A1Q36844764-78C1DD0E-F516-4A59-8C74-669F9BD41BE4Q37302207-5A62F0A6-90CA-4621-B394-2631E80C77EBQ38932270-B8C78EA4-6DCF-43FE-95D5-1E6C6B4C85BFQ39098184-9CC8A466-9A4C-42C5-B82E-5F31034DC35BQ47674493-E5ABD994-9C74-4EFA-AFCC-03584EAD1448
P2860
Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@ast
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@en
type
label
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@ast
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@en
prefLabel
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@ast
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@en
P2093
P2860
P356
P1476
Pharmacokinetic interactions b ...... nd the impact of CYP2D6 status
@en
P2093
Ai-Ming Yu
Donald E Mager
Hong-Wu Shen
Xi-Ling Jiang
P2860
P304
P356
10.1124/DMD.112.050724
P577
2013-02-07T00:00:00Z